Comparative pharmacokinetics study of two extended half-life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A
Latest Information Update: 09 May 2019
At a glance
- Drugs Efmoroctocog alfa (Primary) ; Rurioctocog alfa pegol (Primary)
- Indications Haemophilia A
- Focus Pharmacokinetics
Most Recent Events
- 08 May 2019 New trial record
- 30 Apr 2019 Results published in the Journal of Thrombosis and Haemostasis